Research News / June 01, 2026 / 2026
Improving the Availability of mRNA-Based Drugs
Innovative mRNA-based therapeutics and vaccines offer hope in the fight against cancer, genetic disorders and infections. However, their development and production are complex, slow and difficult to scale. Seven Fraunhofer institutes are working to change this situation. In the RNAuto project, they have now developed an automated, digitally controlled production system that is fast, flexible and cost-effective.
more info
Fraunhofer Institute for Microengineering and Microsystems IMM